L-R: Managing Director/CEO, ISN Medical, Felix Ofungwu; Chairman, Guild of Medical Laboratory Directors, Lagos Chapter, Mrs Mark Doris; Commercial Counsellor and Head of the Trade Office of Finland in Lagos, Mr Eero Toivainen; Director/Head Child Health Division, Family Health Department, Federal Ministry of Health, Abuja, Dr. Amina Mohammed; Paediatrician/Neonatologist/Epidemiologist, UI & UCH, Prof. Adejumoke Ayede; the Chairman, Guild of Paediatricians in Private Practice, Dr. Eletu Seinde; and Rep. Lagos Ministry of Health, Mrs Abimbola Fagbola at the launch of 1 million newborn screening campaign in Lagos recently.
A medical diagnostics company, ISN Medical, has launched a campaign to screen one million newborns in Nigeria for congenital and inherited conditions from 2026 to 2030, aimed at improving early detection, diagnosis, intervention, treatment and child health outcomes in Nigeria and Africa at large.
The initiative, unveiled in Lagos on Friday in partnership with global healthcare innovation company Revvity, seeks to expand access to advanced newborn screening technologies, strengthen local healthcare capacity and improve diagnostic services across Nigeria and Africa.
Speaking at the launch, the Managing Director of ISN Medical, Felix Ofungwu, described the initiative as a milestone in the company’s commitment to transforming healthcare delivery through innovation, accessibility and improved diagnostics.
